[1]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
https://doi.org/10.1016/j.cell.2011.02.013
|
[2]
|
Crusz, S.M. and Balkwill, F.R. (2015) Inflammation and Cancer: Advances and New Agents. Nature Reviews Clinical Oncology, 12, 584-596. https://doi.org/10.1038/nrclinonc.2015.105
|
[3]
|
Hou, J., Karin, M. and Sun, B. (2021) Targeting Can-cer-Promoting Inflammation—Have Anti-Inflammatory Therapies Come of Age? Nature Reviews Clinical Oncology, 18, 261-279. https://doi.org/10.1038/s41571-020-00459-9
|
[4]
|
Diem, S., Schmid, S., Krapf, M., Flatz, L., Born, D., Jochum, W., Templeton, A.J. and Früh, M. (2017) Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Lung Cancer, 111, 176-181.
https://doi.org/10.1016/j.lungcan.2017.07.024
|
[5]
|
Cupp, M.A., Cariolou, M., Tzoulaki, I., Aune, D., Evangelou, E. and Berlanga-Taylor, A.J. (2020) Neutrophil to Lymphocyte Ratio and Cancer Prognosis: An Umbrella Review of Sys-tematic Reviews and Meta-Analyses of Observational Studies. BMC Medicine, 18, Article No. 360. https://doi.org/10.1186/s12916-020-01817-1
|
[6]
|
Zhao, Q.T., Yuan, Z., Zhang, H., Zhang, X.P., Wang, H.E., Wang, Z.K. and Duan, G.C. (2016) Prognostic Role of Platelet to Lymphocyte Ratio in Non-Small Cell Lung Cancers: A Meta-Analysis Including 3,720 Patients. International Journal of Cancer, 139, 164-170. https://doi.org/10.1002/ijc.30060
|
[7]
|
Tan, D., Fu, Y., Tong, W. and Li, F. (2018) Prognostic Significance of Lymphocyte to Monocyte Ratio in Colorectal Cancer: A Meta-Analysis. International Journal of Surgery, 55, 128-138. https://doi.org/10.1016/j.ijsu.2018.05.030
|
[8]
|
Ma, J.Y. and Liu, Q. (2018) Clinicopathological and Prognostic Significance of Lymphocyte to Monocyte Ratio in Patients with Gastric Cancer: A Meta-Analysis. International Journal of Surgery, 50, 67-71.
https://doi.org/10.1016/j.ijsu.2018.01.002
|
[9]
|
Zhang, K., Hua, Y.Q., Wang, D., Chen, L.Y., Wu, C.J., Chen, Z., Liu, L.M. and Chen, H. (2019) Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Advanced Pancreatic Cancer. Journal of Translational Medicine, 17, Article No. 30. https://doi.org/10.1186/s12967-019-1782-x
|
[10]
|
Nie, D., Gong, H., Mao, X. and Li, Z. (2019) Systemic Im-mune-Inflammation Index Predicts Prognosis in Patients with Epithelial Ovarian Cancer: A Retrospective Study. Gyne-cologic Oncology, 152, 259-264.
https://doi.org/10.1016/j.ygyno.2018.11.034
|
[11]
|
Kitahara, H., Shoji, F., Akamine, T., Kinoshita, F., Haratake, N., Takenaka, T., Tagawa, T., Sonoda, T., Shimokawa, M., Maehara, Y. and Mori, M. (2021) Preoperative Prognostic Nu-tritional Index Level Is Associated with Tumour-Infiltrating Lymphocyte Status in Patients with Surgically Resected Lung Squamous Cell Carcinoma. European Journal of Cardio-Thoracic Surgery, 60, 393-401. https://doi.org/10.1093/ejcts/ezab046
|
[12]
|
Wang, X. and Wang, Y. (2019) The Prognostic Nutritional Index Is Prognostic Factor of Gynecological Cancer: A Systematic Review and Meta-Analysis. International Journal of Surgery, 67, 79-86.
https://doi.org/10.1016/j.ijsu.2019.05.018
|
[13]
|
Karn, T., Pusztai, L., Rody, A., Holtrich, U. and Becker, S. (2015) The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Bi-omarkers. Current Cancer Drug Targets, 15, 652-664. https://doi.org/10.2174/156800961508151001101209
|
[14]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[15]
|
McMillan, D.C. (2009) Systemic Inflammation, Nutritional Status and Survival in Patients with Cancer. Current Opinion in Clinical Nutrition & Metabolic Care, 12, 223-226. https://doi.org/10.1097/MCO.0b013e32832a7902
|
[16]
|
Moses, K. and Brandau, S. (2016) Human Neutrophils: Their Role in Cancer and Relation to Myeloid-Derived Suppressor Cells. Seminars in Immunology, 28, 187-196. https://doi.org/10.1016/j.smim.2016.03.018
|
[17]
|
Felix, K. and Gaida, M.M. (2016) Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer-Active Players in Tumor Progression. International Journal of Biological Sciences, 12, 302-313.
https://doi.org/10.7150/ijbs.14996
|
[18]
|
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Gian-nias, B., Bourdeau, F., Kubes, P. and Ferri, L. (2013) Neutrophil Extracellular Traps Sequester Circulating Tumor Cells and Promote Metastasis. Journal of Clinical Investigation, 123, 3446-3458. https://doi.org/10.1172/JCI67484
|
[19]
|
Najmeh, S., Cools-Lartigue, J., Rayes, R.F., Gowing, S., Vourtzoumis, P., Bourdeau, F., Giannias, B., Berube, J., Rousseau, S., Ferri, L.E. and Spicer, J.D. (2017) Neutrophil Extracellular Traps Sequester Circulating Tumor Cells via β1-Integrin Mediated Interactions. International Journal of Cancer, 140, 2321-2330. https://doi.org/10.1002/ijc.30635
|
[20]
|
Labelle, M., Begum, S. and Hynes, R.O. (2011) Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell, 20, 576-590.
https://doi.org/10.1016/j.ccr.2011.09.009
|
[21]
|
Schumacher, D., Strilic, B., Sivaraj, K.K., Wettschureck, N. and Of-fermanns, S. (2013) Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor. Cancer Cell, 24, 130-137.
https://doi.org/10.1016/j.ccr.2013.05.008
|
[22]
|
Stanger, B.Z. and Kahn, M.L. (2013) Platelets and Tumor Cells: A New Form of Border Control. Cancer Cell, 24, 9-11.
https://doi.org/10.1016/j.ccr.2013.06.009
|
[23]
|
Kim, M.R., Kim, A.S., Choi, H.I., Jung, J.H., Park, J.Y. and Ko, H.J. (2020) Inflammatory Markers for Predicting Overall Survival in Gastric Cancer Patients: A Systematic Review and Meta-Analysis. PLOS ONE, 15, E0236445.
https://doi.org/10.1371/journal.pone.0236445
|
[24]
|
Cao, W., Yao, X., Cen, D., Zhi, Y., Zhu, N. and Xu, L. (2020) The Prognostic Role of Platelet-to-Lymphocyte Ratio on Overall Survival in Gastric Cancer: A Systematic Review and Meta-Analysis. BMC Gastroenterolog, 20, Article No. 16. https://doi.org/10.1186/s12876-020-1167-x
|
[25]
|
Wang, B., Huang, Y. and Lin, T. (2020) Prognostic Impact of Elevated Pre-Treatment Systemic Immune-Inflammation Index (SII) in Hepatocellular Carcinoma: A Meta-Analysis. Medicine (Baltimore), 99, E18571.
https://doi.org/10.1097/MD.0000000000018571
|
[26]
|
Wang, Y., Li, Y., Chen, P., Xu, W., Wu, Y. and Che, G. (2019) Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index (SII) in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis. Annals of Translational Medicine, 7, 433. https://doi.org/10.21037/atm.2019.08.116
|
[27]
|
Chen, J.H., Zhai, E.T., Yuan, Y.J., Wu, K.M., Xu, J.B., Peng, J.J., Chen, C.Q., He, Y.L. and Cai, S.R. (2017) Systemic Immune-Inflammation Index for Predicting Prognosis of Colorectal Cancer. World Journal of Gastroenterology, 23, 6261-6272. https://doi.org/10.3748/wjg.v23.i34.6261
|
[28]
|
Qiu, Y., Zhang, Z. and Chen, Y. (2021) Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Can-cer: A Meta-Analysis. Frontiers in Oncology, 11, Article ID: 537140.
https://doi.org/10.3389/fonc.2021.537140
|
[29]
|
Shi, H., Jiang, Y., Cao, H., Zhu, H., Chen, B. and Ji, W. (2018) Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients. Dis-ease Markers, 2018, Article ID: 1787424.
https://doi.org/10.3389/fonc.2021.537140
|
[30]
|
Tomita, M., Ayabe, T. and Nakamura, K. (2018) The Advanced Lung Cancer Inflammation Index Is an Independent Prognostic Factor after Surgical Resection in Patients with Non-Small-Cell Lung Cancer. Interdisciplinary CardioVascular and Thoracic Surgery, 26, 288-292. https://doi.org/10.1093/icvts/ivx329
|